Latest News about Fda
Recent news which mentions Fda
Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
April 12, 2024
From Benzinga
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies
April 12, 2024
From Benzinga
FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling
April 12, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
From Benzinga
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
From Benzinga
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
April 08, 2024
From Benzinga
From Benzinga
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
April 05, 2024
From Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
April 05, 2024
From Benzinga
Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
April 04, 2024
From Benzinga
Why Is Vanda Pharmaceuticals Stock Trading Higher Today?
April 03, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.